SUNNYVALE, Calif., Nov. 8, 2010 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today financial results for the first quarter of fiscal year 2011, ended September 30, 2010. For the first quarter of fiscal 2011, Accuray reported
Inventory Investigation Concluded SUNNYVALE, Calif ., Dec. 18 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today financial results for the first quarter of fiscal 2009, ended September 27, 2008 .
Transformative Technology Launch at Leading Radiation Oncology Meeting Sets Stage for Future Growth SUNNYVALE, Calif. , Nov. 7, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today financial results for the first quarter of fiscal 2013
Q1 Highlights: Revenue Growth and Service Gross Margin Improvement SUNNYVALE, Calif., Nov. 8, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company , announced today financial results for the first quarter of fiscal 2012 that ended September 30,
SUNNYVALE, Calif. , Oct. 29 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today financial results for the first quarter of fiscal year 2010, ended September 30, 2009 . For the first quarter of fiscal 2010, Accuray reported
SUNNYVALE, Calif. , Jan. 19, 2016 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced that between January 11 and January 15, 2016 , the company, in privately-negotiated transactions, had repurchased approximately $63.4 million in aggregate principal amount of its 3.75% Convertible
New Organization Drives Focus on Sales and Revenue Growth SUNNYVALE, Calif., Oct 21, 2009 /PRNewswire-FirstCall via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today plans to establish an America's region thereby establishing regionalized
Key Milestone Reached with More Than 100 Systems Now in Use Worldwide SUNNYVALE, Calif., Oct. 26, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today significant momentum in global adoption of its TomoDirect treatment modality
SUNNYVALE, Calif. , Feb. 6, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) (" Accuray ") today announced its intention to commence an offering, subject to market and other conditions, of $75 million aggregate principal amount of convertible senior notes due 2018 (the "notes"), to be
SUNNYVALE, Calif., July 26, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY) ("Accuray") today announced its intention to commence an offering, subject to market and other conditions, of $75 million aggregate principal amount of convertible senior notes due 2016 (the "notes"), to
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
